Fluid retention during arsenic trioxide treatment in acute promyelocytic leukemia.
Arai
Ayako
A
Kitano
Asako
A
Kurosu
Tetsuya
T
Yamamoto
Koh
K
Miki
Tohru
T
Murakami
Naomi
N
Miura
Osamu
O
D000368:Aged; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D001854:Bone Marrow Cells; D004487:Edema / Q000209:etiology*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000473:pathology*; D007958:Leukocyte Count; D008297:Male; D010087:Oxides / Q000009:adverse effects*
D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide